biohazard sign

The Institutional Biosafety Committee (IBC) was established under the provisions of the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines). The role of the IBC is to establish and implement policies that provide for the safe conduct of recombinant DNA research and to ensure compliance with the NIH Guidelines. In addition, the IBC oversees research involving infectious agents and toxic biological molecules. The IBC also reviews research protocols from grant applications submitted to extramural funding agencies to confirm that experiments will be conducted safely and in compliance with the NIH Guidelines. Members of the IBC are appointed by the Vice President for Research and Biotechnology and include persons who are not otherwise affiliated with the University to represent the interests of the surrounding community with respect to health and protection of the environment.



Dual Use Research

Dual Use Research of Concern Committee 

Dual Use Research of Concern Policy


 NIH Information for Institutional Biosafety Committees

 NIH Training and Educational Materials for IBCs

 NIH Information Educational Materials on Dual Use Research



page updated on 5/10/2017, ng